Literature DB >> 18200349

[Prevalence of genital HPV infection among women screened for cervical cancer].

Cristina Helena Rama1, Cecilia Maria Roteli-Martins, Sophie Françoise Mauricette Derchain, Adhemar Longatto-Filho, Renata Clementino Gontijo, Luís Otávio Zanatta Sarian, Kari Syrjänen, José Mendes Aldrighi.   

Abstract

OBJECTIVE: To assess the prevalence of high-risk genital human papillomavirus (HPV) infection by age group and risk factors associated.
METHODS: Cross-sectional study in a sample of 2,300 women (15-65 years old) who self-referred to cervical cancer screening in Sao Paulo and Campinas, Southeastern Brazil, between February 2002 and March 2003. An epidemiological questionnaire was applied and cervical specimens were obtained for cytology and hybrid capture II test (HCII) for HPV detection. Statistical analysis included Pearson Chi-square and unconditional multiple logistic regression model (forward likelihood ratio).
RESULTS: High-risk genital HPV infection prevalence in this sample was 17.8% and age distribution was as follows: 27.1% (<25 years), 21.3% (25-34 years), 12.1% (35-44 years), 12.0% (45-54 years) and 13.9% (55-65 years). Subjects with the highest number of lifetime sexual partners had the highest rates of genital HPV infection. To be living with a partner, aged 35 to 44 years, and former smokers were protective factors. High-risk genital HPV infection was 14.3% in normal cytology, 77.8% in high grade squamous intraepithelial lesions and in the two cases (100%) of cervical cancer.
CONCLUSIONS: High-risk HPV prevalence was high in the sample studied. The highest prevalence of HPV infection was seen in women under 25 years old and then a new increase was seen over the age of 55 and the highest rates were found among those with many sexual partners during their lifetime.

Entities:  

Mesh:

Year:  2008        PMID: 18200349     DOI: 10.1590/s0034-89102008000100016

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  12 in total

1.  Oral and genital HPV genotypic concordance between sexual partners.

Authors:  Camila Maria Beder Ribeiro; Iracema Ferrer; Andreza Barkokebas Santos de Farias; Débora Diniz Fonseca; Igor Henrique Morais Silva; Luiz Alcino Monteiro Gueiros; Alessandra Tavares Carvalho; Stephen Ross Porter; Jair Carneiro Leao
Journal:  Clin Oral Investig       Date:  2013-03-14       Impact factor: 3.573

2.  The Prevalence of Genus Alpha Human Papillomavirus in Women with Uterine Cervical Infection and/or Inflammation in Western Iran.

Authors:  Seyed Ghasem Mirbahari; Masoud Sadeghi
Journal:  Mater Sociomed       Date:  2018-06

3.  Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing.

Authors:  Emily N Beylerian; Rose C Slavkovsky; Francesca M Holme; Jose A Jeronimo
Journal:  J Low Genit Tract Dis       Date:  2018-07       Impact factor: 1.925

4.  Evaluation of HPV E6/E7 mRNA Detection in Clinically Suspected Cases of Cervical Cancer with Abnormal Cytology: Time to Upgrade the Screening Protocols.

Authors:  Bhawna Sharma; Vikas Lakhanpal; Kanwardeep Singh; Loveena Oberoi; Preet Kamal Bedi; Pushpa Devi
Journal:  J Lab Physicians       Date:  2022-07-04

5.  Maternal transmission of human papillomavirus in retinoblastoma: A possible route of transfer.

Authors:  Anand Bhuvaneswari; V R Pallavi; R S Jayshree; Rekha V Kumar
Journal:  Indian J Med Paediatr Oncol       Date:  2012-10

6.  Transplacental transmission of Human Papillomavirus.

Authors:  Renato L Rombaldi; Eduardo P Serafini; Jovana Mandelli; Edineia Zimmermann; Kamille P Losquiavo
Journal:  Virol J       Date:  2008-09-25       Impact factor: 4.099

7.  Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.

Authors:  Aline Beckenkamp; Júlia Biz Willig; Danielle Bertodo Santana; Jéssica Nascimento; Juliano Domiraci Paccez; Luiz Fernando Zerbini; Alessandra Nejar Bruno; Diogo André Pilger; Márcia Rosângela Wink; Andréia Buffon
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

8.  The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada.

Authors:  Ying Jiang; Paul Brassard; Alberto Severini; Yang Mao; Y Anita Li; Julie Laroche; Susan Chatwood; Andre Corriveau; Kami Kandola; Brendan Hanley; Isaac Sobol; Muna Ar-Rushdi; Gordon Johnson; Jane Lo; Sam Ratnam; Tom Wong; Alain Demers; Gayatri Jayaraman; Stephanie Totten; Howard Morrison
Journal:  Infect Agent Cancer       Date:  2013-07-01       Impact factor: 2.965

9.  Identifying populations most susceptible to get benefit from broadening the scope for prevention of cervical cancer: Example from Uruguay.

Authors:  Víctor-Guillermo Sequera; Marisa Mena; Malen Hollmann; Estefani Mani; Viviana Ramas; Sylvia Bonilla; Alicia Guerra; Fernando Borgia
Journal:  Papillomavirus Res       Date:  2018-03-16

10.  Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians.

Authors:  Ana Carolina da Silva Santos; Nayara Nascimento Toledo Silva; Cláudia Martins Carneiro; Wendel Coura-Vital; Angélica Alves Lima
Journal:  BMC Public Health       Date:  2020-03-06       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.